Most of the health stocks on my watchlist are in the green, the exception is NEU. Some dissonance going on here when viewed through the prism of potential FDA approval, US$73 million payments and ROW deal.
Looked at some health stocks over the past few days to try to draw a conclusion about what’s happening with NEU. Telix and Clinuvel rode the back of share price rallies culminating in FDA approval, NEU is descending quickly from the low $9s right before FDA approval. Not sure what to make of it still, strange times. But as a few posters have projected already this could slingshot straight back up on approval (past $10 at a minimum I’m guessing/hoping). Someone may have decided to cash out of the recent rally, just very odd given how close to PDUFA we are.
Share Price, page-3831
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.71 |
Change
-0.590(3.41%) |
Mkt cap ! $2.135B | |||
| Open | High | Low | Value | Volume |
| $17.50 | $17.55 | $16.57 | $10.01M | 594.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 598 | $16.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.87 | 1676 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |